Project Number 5R61AG067916-03 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Molecular imaging of RIPK1/necroptosis as a key biomarker in Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 2. Imaging Biomarkers c. PET Other Imaging Researcher and Organization Principal Investigator WANG, CHANGNING Principal Investigator First Name CHANGNING Principal Investigator Last Name WANG Awardee Organization MASSACHUSETTS GENERAL HOSPITAL Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-19-315: Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional) FY Overall Cost $832,432 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official HSIAO, JOHN
